Highlights
Recent News
BioNTech Faces a Summer of Reckoning as Vaccine Revenues Wane and Oncology Data Takes Center Stage
BioNTech enters a critical stretch with no single event to anchor investor sentiment. The German biotech’s stock closed at €80.20...
Volkswagen’s Pre-Close Call Looms as China Sales Collapse and Board Impasse Deepen
Volkswagen enters one of its most treacherous trading periods in recent memory, with the stock clinging to its 52-week low...
IBM’s AI Monetization Test Narrows to One Earnings Report
Friday’s 2.28% slide in IBM’s shares, which closed at €252.40, could easily be dismissed as a garden-variety pullback after a...
Siemens Energy Caught Between Berlin’s Policy Pivot and AI-Linked Volatility as JPMorgan Holds Firm
Siemens Energy is navigating a tricky stretch as the German policy landscape shifts under its feet while its share price...
Popular
Net Worth
Valneva’s Binary Outlook: A Broken Commercial Business Versus a Potentially Blockbuster Pipeline
For investors in Valneva, the gap between hope and reality has rarely been wider. The French biotech’s...
Lam Research: Analyst Price Targets Soar to $425 as the Stock Holds Its Breath
The semiconductor equipment maker Lam Research finds itself in an odd spot. Its shares have barely budged...
The $650 Billion Question Behind This Quarter’s Rally
Dear readers, Yesterday we flagged a market priced for perfection, with Michael Hartnett's Bull & Bear Indicator...
Broadcom’s Longest Bet Yet: A $30 Billion Apple Pact Runs Through 2031 While AI Custom Silicon Hits Stride
The Broadcom stock story in the first half of 2026 has been one of a blistering rally...